佛塑科技(000973.SZ)半年度淨利潤預增99.78%-133.08%
格隆匯7月12日丨佛塑科技(000973.SZ)披露半年度業績預吿,預計2021年半年度歸屬於上市公司股東的淨利潤為6000萬元-7000萬元,同比增長99.78%-133.08%。
據悉,面對國內外經濟形勢變化、大宗原材料價格波動加大和市場風險加劇等不穩定不確定因素顯著增多的外部環境,公司抓住經濟恢復及部分產品市場需求增加的機遇,攻堅克難,奮力拼搏,緊緊圍繞新材料產業發展定位,加大研發技術創新,推動精細化管理,提高產品競爭力,抓住市場機遇,深挖優勢產品的市場需求,公司主業利潤實現大幅增長。2021年上半年歸屬於上市公司股東的淨利潤比2020年同期大幅上升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.